CStone Pharmaceuticals

OTCPK:CSPH.F Stock Report

Market Cap: US$909.6m

CStone Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?

Recent Insider Transactions

OTCPK:CSPH.F Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
10 Jun 26BuyUS$78,806Jianxin YangIndividual145,000US$0.54
09 Jun 26BuyUS$108,583Jianxin YangIndividual200,000US$0.54
08 Jun 26BuyUS$228,611Kenneth Walton HitchnerIndividual400,000US$0.57
05 Jun 26BuyUS$121,376Jianxin YangIndividual200,000US$0.61
03 Jun 26BuyUS$65,348Jianxin YangIndividual105,000US$0.62
15 Apr 26BuyUS$9,626,751Morgan StanleyCompany7,959,183US$1.21
15 Apr 26BuyUS$29,998,738Hillhouse Investment Management, Ltd.Company26,200,000US$1.14
02 Apr 26SellUS$2,967,368GIC Private LimitedCompany2,520,000US$1.18
27 Mar 26SellUS$12,867,518GIC Private LimitedCompany12,414,500US$1.04
26 Mar 26SellUS$2,726,152GIC Private LimitedCompany3,017,000US$0.90
23 Jan 26BuyUS$104,224Jianxin YangIndividual148,500US$0.70
22 Jan 26BuyUS$196,580Jianxin YangIndividual280,000US$0.70
06 Jan 26SellUS$3,310Jianxin YangIndividual4,817US$0.69
23 Dec 25BuyUS$679,987GIC Private LimitedCompany904,500US$0.75
04 Dec 25BuyUS$739,454Zhengguo HuIndividual1,000,000US$0.74
14 Nov 25BuyUS$31,602Jianxin YangIndividual40,000US$0.79
13 Nov 25BuyUS$81,935Jianxin YangIndividual117,500US$0.70
12 Nov 25BuyUS$49,445Jianxin YangIndividual70,000US$0.71
11 Nov 25BuyUS$68,778Jianxin YangIndividual100,000US$0.69
03 Nov 25BuyUS$177,586Jianxin YangIndividual220,000US$0.81
21 Oct 25BuyUS$276,417Jianxin YangIndividual300,000US$0.92
20 Oct 25BuyUS$347,062Jianxin YangIndividual400,000US$0.87
13 Oct 25BuyUS$2,022,098GIC Private LimitedCompany2,261,000US$0.89
25 Sep 25BuyUS$150,342Jianxin YangIndividual150,000US$1.00
09 Sep 25SellUS$818,583Kenneth Walton HitchnerIndividual500,000US$1.64
05 Sep 25SellUS$343,448Zhengguo HuIndividual223,000US$1.54
04 Sep 25SellUS$350,073Zhengguo HuIndividual227,000US$1.54
03 Sep 25SellUS$61,031Jianxin YangIndividual39,375US$1.55
20 Aug 25SellUS$121,346,6406 Dimensions Capital LimitedCompany120,000,000US$1.01
18 Aug 25BuyUS$81,242,431GIC Private LimitedCompany80,400,000US$1.01
14 Jul 25BuyUS$6,624Jianxin YangIndividual10,000US$0.66

Insider Trading Volume

Insider Buying: CSPH.F insiders have bought more shares than they have sold in the past 3 months.

Ownership Breakdown

What is the ownership structure of CSPH.F?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders25,309,6111.58%
Public Companies115,928,8037.25%
VC/PE Firms262,045,94416.4%
Institutions341,809,42921.4%
General Public853,115,54653.4%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.8%.

Top Shareholders

Top 25 shareholders own 46.53% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.9%
6 Dimensions Capital Limited
173,381,444US$98.7m0%38.63%
7.25%
Pfizer Inc.
115,928,803US$66.0m0%no data
5.55%
Hillhouse Investment Management, Ltd.
88,664,500US$50.5m0%0.23%
4.76%
GIC Private Limited
76,040,500US$43.3m-26.3%0.06%
4.49%
Morgan Stanley
71,812,963US$40.9m6.08%no data
4.01%
Suzhou Oriza Holdings Co., Ltd.
64,030,316US$36.4m0%1.62%
2.5%
Boyu Capital Group Management Ltd.
40,017,948US$22.8m0%1.72%
2.31%
Vanguard Capital Management, LLC
36,895,500US$21.0m0.42%no data
1.27%
Jianxin Yang
20,249,808US$11.5m2.56%no data
1.2%
BlackRock, Inc.
19,153,500US$10.9m-2.55%no data
0.61%
Vanguard Fiduciary Trust Company
9,678,000US$5.5m0%no data
0.34%
JP Morgan Asset Management
5,388,500US$3.1m0%no data
0.21%
E Fund Management Co., Ltd.
3,310,200US$1.9m0%no data
0.18%
Invesco Capital Management LLC
2,843,903US$1.6m0%no data
0.17%
State Street Global Advisors, Inc.
2,754,000US$1.6m-0.29%no data
0.16%
Principal Global Investors, LLC
2,589,500US$1.5m0%no data
0.13%
Kenneth Walton Hitchner
2,113,481US$1.2m0%no data
0.12%
Zhengguo Hu
1,950,163US$1.1m3.31%no data
0.12%
Franklin Resources, Inc.
1,915,430US$1.1m0%no data
0.094%
HSBC Global Asset Management (Hong Kong) Limited
1,495,000US$850.8k0%0.02%
0.061%
Wei Li
979,159US$557.3k104%no data
0.049%
Dacheng Fund Management Co., Ltd.
780,000US$443.9k0%no data
0.04%
Geode Capital Management, LLC
636,714US$362.4k1.95%no data
0.036%
China Universal Asset Management Company Ltd.
575,100US$327.3k0%no data
0.031%
ICBC Credit Suisse Fund Management Co., Ltd
500,000US$284.6k0%no data

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/06/12 03:19
End of Day Share Price 2026/06/01 00:00
Earnings2025/12/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

CStone Pharmaceuticals is covered by 6 analysts. 4 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution
Ziyi ChenGoldman Sachs
null nullGuoyuan Securities (HK) Ltd
Hanyang HuangIndustrial Securities Co. Ltd.